Fig. 3 | Signal Transduction and Targeted Therapy

Fig. 3

From: Development and validation of dynamic clinical subphenotypes in acute pancreatitis patients using vital sign trajectories in intensive care units: a multinational cohort study

Fig. 3

The Kaplan–Meier of 30-day mortality for subphenotypes in development and validation cohorts. a represented the KM curve of 30-day mortality across AP subphenotypes in the development cohort, while (b) represented the KM curve of 30-day mortality across AP subphenotypes in the validation cohort; KM curves were adjusted by demographic characteristics (age, gender, and race)

Back to article page